Skip to main content

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

National Institutes of Health

open
OpenLast verified: 2026-07-05

About This Grant

This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA PAR-.The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups , including low-income, lower-middle-income, and upper-middle-income countries). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

Grant Summary

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) is a National Institutes of Health grant providing funding that varies by award. Applications are due 2026-12-03 (open). Check eligibility and apply with FindGrants.

Focus Areas

education

Eligibility

Funder did not publish eligibility criteria — confirm directly with the funder before applying.

How to Apply

Funding Range

Up to $0K

Deadline

2026-12-03

Complexity
Medium
  1. 1Confirm your organization is eligible for Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) from National Institutes of Health, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Start Application

Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.

Don't want to draft it yourself?

We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed): Frequently Asked Questions

Who is eligible for the Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)?

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) is offered by National Institutes of Health and is generally open to eligible organizations. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) provide?

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) provides an amount that varies by award per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) deadline?

Applications for Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) are due 2026-12-03 (open). Because deadlines can change, verify the date with the funder, National Institutes of Health, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)?

To apply for Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.

Browse More Grants